SCHEMBL623294

SCHEMBL623294

O=C(O)c1ccc(NC(=O)C(OC2CCCCC2)c2ccc(S(=O)(=O)C3CC3)cc2)nc1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL624177 0.95 GCK (0.63) GCK
SCHEMBL10140456 0.92 GCK (0.63) GCK
SCHEMBL11972013 0.91 GCK (0.67) GCK
SCHEMBL624246 0.88 GCK (0.65) GCK
SCHEMBL622606 0.87 GCK (0.53) GCK
SCHEMBL184757 0.86 GCK (0.63) GCK
SCHEMBL624312 0.86 GCK (0.59) GCK
SCHEMBL624729 0.84 GCK (0.65) GCK
SCHEMBL622631 0.84 GCK (0.55) GCK
SCHEMBL623515 0.81 GCK (0.61) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO claimed
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO disclosed